Moderate-level resistance to glycopeptide LY333328 mediated by genes of the vanA and vanB clusters in enterococci. - Wikidata - awgldk - TriplyDB

Moderate-level resistance to glycopeptide LY333328 mediated by genes of the vanA and vanB clusters in enterococci.

Moderate-level resistance to glycopeptide LY333328 mediated by genes of the vanA and vanB clusters in enterococci.

http://www.wikidata.org/entity/Q39471427

about

Lactate racemization as a rescue pathway for supplying D-lactate to the cell wall biosynthesis machinery in Lactobacillus plantarum.Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infections Antimicrobial Peptides Targeting Gram-Positive Bacteria Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis In vitro activities of LY333328 and comparative agents against nosocomial gram-positive pathogens collected in a 1997 global surveillance study.Activity of oritavancin (LY333328), an investigational glycopeptide, compared to that of vancomycin against multidrug-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model.Regulation of VanA- and VanB-type glycopeptide resistance in enterococci Synthesis and evaluation of selected key methyl ether derivatives of vancomycin aglycon.Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin.VanD-type vancomycin-resistant Enterococcus faecium 10/96A.Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections Modes and modulations of antibiotic resistance gene expression.Vancomycin and oritavancin have different modes of action in Enterococcus faecium

P2860

Q24534040-45EB9F10-B504-4217-B0F1-7870ED01480D Q26799701-4D190F55-FA95-4D66-9D9E-D694A8058314 Q28077888-0A47FA7E-F205-4DBC-AADC-FC1C8FB99BE8 Q33594048-3DB24B82-9C8B-43AC-A644-B10633464E84 Q33979559-C7960976-1D96-4938-8F97-8404BEF69F10 Q33981579-48D92075-053F-4530-8914-3BCBA33D5905 Q34131478-09B838F3-0523-47EA-BA8C-91DCC328A4A1 Q34308628-6917C27E-65A3-451C-97D1-A06E4B0EEA59 Q34448260-A9C82A16-E11D-43CC-AAB9-BA0A933120E3 Q35033455-DCCA34BF-7917-4009-AA47-33B45AA3D1E5 Q36393640-0BD6103A-2C13-46DB-93EA-896C7A6630C1 Q36708242-88AECD61-1B61-4331-B9A8-86DAA8C0F551 Q37356329-65362707-43AC-4FA7-89B1-97D128BDE06A

P2860

Moderate-level resistance to glycopeptide LY333328 mediated by genes of the vanA and vanB clusters in enterococci.

http://www.wikidata.org/entity/Q39471427

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

Moderate-level resistance to g ...... vanB clusters in enterococci.

@en

Moderate-level resistance to g ...... vanB clusters in enterococci.

@nl

type

label

Moderate-level resistance to g ...... vanB clusters in enterococci.

@en

Moderate-level resistance to g ...... vanB clusters in enterococci.

@nl

prefLabel

Moderate-level resistance to g ...... vanB clusters in enterococci.

@en

Moderate-level resistance to g ...... vanB clusters in enterococci.

@nl

P1433

Q39471427-910657E9-7C05-4CEF-92D2-77237D6784AE

P1476

Q39471427-2551D273-2921-4C2E-96D0-219D79841685

P2093

Q39471427-356A4F54-7980-497D-B139-EB6AE7866DD6

Q39471427-6F49FA3D-F364-4620-ADD0-1CF3626804B9

Q39471427-B53644B1-F14F-4C7B-8B35-B7AD0A6E5872

Q39471427-F4CBB9F3-522F-46AA-AF47-F537C1DD04E3

P2860

Q39471427-03A8D1A0-0F1F-4AF2-9D04-64681CE21025

Q39471427-0608AE7F-F500-4DB4-B600-6449AA9265BF

Q39471427-063698BA-7295-4361-986C-78168CA691D0

Q39471427-1B7E894F-79E7-4DAC-96B4-CE36DAA79ADA

Q39471427-21EE8EC3-23D9-41CB-B02C-E8C922177BA0

Q39471427-26F086A8-29B1-415D-9DE3-B7D803D80324

Q39471427-3778405C-839A-4A35-B336-BAF8D8161A0F

Q39471427-3F1B8BEA-D8FB-4749-97AC-88E52D6769CE

Q39471427-428174C2-201F-43D4-B72E-760CAB6C7D0D

Q39471427-42B3037A-2052-47B7-A2BD-5598C6999DC3

P304

Q39471427-1ACB8283-40DD-48A3-B047-CF41A8640FF1

P31

Q39471427-6B0880D2-F5A1-4620-901B-55D4FCF59E69

P356

Q39471427-CED0D99A-0F0A-488B-96B6-452D7B7BBEEA

P407

Q39471427-E56758F9-4153-4658-99EA-38430DDD7D45

P433

Q39471427-74097A04-60FB-4559-844D-0520EC9B8C4F

P478

Q39471427-AD6286E2-93DF-4FA5-84DE-EA15BD9375D0

P577

Q39471427-800D2FDF-7811-47B9-BE8D-A4262A19D435

P698

Q39471427-D49FAB92-E489-432F-930E-6F6DDE73388D

P932

Q39471427-D7259032-DE70-4340-9FD0-769E732E49AB

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Moderate-level resistance to g ...... d vanB clusters in enterococci

@en

P2093

F Depardieu

http://www.w3.org/2001/XMLSchema#string

M Arthur

http://www.w3.org/2001/XMLSchema#string

P Courvalin

http://www.w3.org/2001/XMLSchema#string

P Reynolds

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)-VanR (B) two-component regulatory system in Enterococcus faecalis V583

Contribution of VanY D,D-carboxypeptidase to glycopeptide resistance in Enterococcus faecalis by hydrolysis of peptidoglycan precursors.

Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants.

Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis.

Synergy of an investigational glycopeptide, LY333328, with once-daily gentamicin against vancomycin-resistant Enterococcus faecium in a multiple-dose, in vitro pharmacodynamic model

Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA.

Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium.

In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide

The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction.

Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci.

P304

1875-1880

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.43.8.1875

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

1999-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10428906

http://www.w3.org/2001/XMLSchema#string

P932

89384

http://www.w3.org/2001/XMLSchema#string